CHR Metz-Thionville
Metz, 57085, France
Location status: Recruiting
NCT Number: NCT07406022
Skin carcinomas are the most commonly diagnosed cancers in fair-skinned populations, for example in France, Western Europe, and North America in particular. The OpticSkin project will build and make available to the general public and the scientific and medical community a histological and optical spectroscopic database of healthy, precancerous, and cancerous human skin in terms of absorption, elastic and inelastic scattering (Raman), steady-state and time-resolved autofluorescence, and polarization. The aim is to identify spectroscopic signatures that will be useful for diagnosis.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Metz, 57085, France
Location status: Recruiting
The Priority Research Program and Equipment for Light-Matter (PEPR LUMA) has granted its support to the OpitcSkin project, which aims to provide diagnostic information that complements that currently provided by histology for the diagnosis of skin carcinomas, the most common cancers among fair-skinned populations. In recent years, several imaging and optical spectroscopy modalities have been evaluated in vivo in clinical settings to quantify the real-time diagnostic assistance they provide to clinicians performing surgical resection of skin carcinomas. Imaging methods such as confocal reflectance microscopy, optical coherence tomography, and nonlinear optical microscopy provide morphological information that improves diagnostic accuracy and reduces the risk of recurrence by allowing immediate verification after surgery that the tumor has been completely removed.
Spectroscopic methods, including Raman spectroscopy and autofluorescence, which are also applied in vivo, provide additional structural and functional information, for example on metabolism, further improving diagnostic accuracy. In all cases, studies have shown that combining multiple optical imaging and/or spectroscopy modalities, as well as data analysis and/or machine learning methods, offers better diagnostic accuracy than each modality taken individually.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Until the end of the study on average 2 years
automated recognition (by supervised classification) of optical data acquired on different histological classes
Contact information is provided by the study sponsor or research team.
Andreia CARVALHO DE FREITAS
CONTACT
Grégoire Khairallah
CONTACT
Centre Hospitalier Régional Metz-Thionville
Other
Acronym: OpticSkin
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07624981
Diagnostic, Disease
Metz, France
View Trial DetailsNCT07042243
Behavior, Behavior, Animal
Gainesville, Florida, United States
View Trial DetailsNCT04122456
Neoplasms, Neoplasms by Site
Fairborn, Ohio, United States
View Trial DetailsNCT06615635
Alpha Radiation, Brachytherapy
Gilbert, Arizona, United States
View Trial Details